Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve

NCT03003299 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03003299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03003299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Recruiting
Start date
January 5, 2017
Completion date
April 30, 2038
Enrollment
125 (estimated)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, aortic stenosis, severe